• Return to Headlines

Phibro Animal-A has the Lowest EBITDA Growth in the Pharmaceuticals Industry (PAHC, PRGO, LCI, ZTS, JNJ)

By James Quinn

Below are the three companies in the Pharmaceuticals industry with the lowest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Phibro Animal-A ranks lowest with a EBITDA growth of 10.4%. Following is Perrigo Co Plc with a EBITDA growth of 13.3%. Lannett Co Inc ranks third lowest with a EBITDA growth of 15.5%.

Zoetis Inc follows with a EBITDA growth of 21.2%, and Johnson&Johnson rounds out the bottom five with a EBITDA growth of 21.9%.

SmarTrend is tracking the current trend status for Phibro Animal-A and will alert subscribers who have PAHC in their portfolio or watchlist when shares have changed trend direction.

Keywords: lowest ebitda growth phibro animal-a perrigo co plc lannett co inc zoetis inc Johnson&Johnson

Ticker(s): PAHC PRGO LCI ZTS JNJ